menu
    • menu

    Company profile for IFM Therapeutics

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At IFM Therapeutics, LLC, we are transforming immunotherapy to improve the lives of patients with serious diseases. We focus on developing small molecule drugs that precisely target the innate immune system, the body’s first line of immunological response. IFM Therapeutics, LLC was formed following the acquisition of IFM Therapeutics by Bristol-Myers Squibb in 2017. IFM Therapeutics, LLC retained its personnel and facilitie...
    At IFM Therapeutics, LLC, we are transforming immunotherapy to improve the lives of patients with serious diseases. We focus on developing small molecule drugs that precisely target the innate immune system, the body’s first line of immunological response. IFM Therapeutics, LLC was formed following the acquisition of IFM Therapeutics by Bristol-Myers Squibb in 2017. IFM Therapeutics, LLC retained its personnel and facilities, as well as its remaining research programs focused on curbing immune responses that lead to inflammatory diseases and fibrosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IFM TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    855 Boylston Street, 11th Floor, Boston, MA 02116
    Telephone
    Telephone
    +1-857-304-0583
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ifmthera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ifmtherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ifmthera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Serial entrepreneur Gary Glick sells another one of his startups for $290M
    Serial entrepreneur Gary Glick sells another one of his startups for $290M

    13 Sep 2021

    // ENDPTS

    https://endpts.com/serial-entrepreneur-gary-glick-sells-another-one-of-his-startups-for-290m-this-time-to-an-unlikely-buyer/

    ENDPTS
    13 Sep 2021
    Share Share
    IFM Therapeutics Announces $55.5 Million Financing
    IFM Therapeutics Announces $55.5 Million Financing

    02 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ifm-therapeutics-announces-55-5-million-financing-to-launch-and-fund-new-subsidiaries-and-appointment-of-dr-h-martin-seidel-as-chief-executive-officer-300967030.html

    PR NEWSWIRE
    02 Dec 2019
    Share Share
    IFM gets new CEO, bags another $55M to launch incubator, new subsidiaries
    IFM gets new CEO, bags another $55M to launch incubator, new subsidiaries

    02 Dec 2019

    // A. A Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ifm-gets-new-ceo-bags-another-55m-to-launch-incubator-new-subsidiaries

    A. A Idrus FIERCE BIOTECH
    02 Dec 2019
    Share Share
    IFM Announces $55.5 Million Financing to Launch and Fund New Subsidiaries
    IFM Announces $55.5 Million Financing to Launch and Fund New Subsidiaries

    02 Dec 2019

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ifm-therapeutics-announces-55-5-million-financing-to-launch-and-fund-new-subsidiaries-and-appointment-of-dr-h-martin-seidel-as-chief-executive-officer-300967030.html

    PRNEWSWIRE
    02 Dec 2019
    Share Share
    New Research Demonstrates Direct Link Between Inflammasome and Alzheimer's
    New Research Demonstrates Direct Link Between Inflammasome and Alzheimer's

    21 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-research-demonstrates-second-direct-link-between-inflammasome-activation-and-alzheimers-disease-300962374.html

    PR NEWSWIRE
    21 Nov 2019
    Share Share
    Novartis, IFM Due ink R&D deal—with $840M buyout option
    Novartis, IFM Due ink R&D deal—with $840M buyout option

    06 Sep 2019

    // Amirah.A. Drus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/novartis-bankrolls-ifm-due-s-cgas-sting-pipeline-840m-buyout-option

    Amirah.A. Drus FIERCE BIOTECH
    06 Sep 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search